Epidemiology of carbapenem resistance Enterobacterales in Saudi Arabia: A systematic review
Keywords:Carbapenem, Enterobacteriaceae, Saudi Arabia, lactamase, resistant, carbapenemase
The widespread of multidrug-resistant bacteria, particularly carbapenem-resistant Enterobacterales (CRE) bacteria, constitutes a major public health threat worldwide, owing to the limited therapeutic options. This review will describe and uncover the Saudi experience in the challenge against carbapenem resistance (CR). The different carbapenem resistance prevalence and carbapenemase genes detected from various bacterial species were mapped for Saudi regional distribution, based on Saudi published data during a period extended from 2017 to 2021. However, VIM, IMP, and KPC enzymes were usually reported with the predominance of OXA and NDM among Enterobacterales. Although SIM and GIM carbapenemases were uncommonly detected in our country. Collaborative efforts and raising awareness of the threat of carbapenem resistance are required to minimize the spread of multidrug-resistant bacteria.
Abd El Ghany, M., H. Sharaf, M. H. Al-Agamy, A. Shibl, G. A. Hill-Cawthorne and P.-Y. Hong (2018). "Genomic characterization of NDM-1 and 5, and OXA-181 carbapenemases in uropathogenic Escherichia coli isolates from Riyadh, Saudi Arabia." PloS one13(8): e0201613.
Abdallah, M., R. Alhababi, N. Alqudah, B. Aldyyat and A. Alharthy (2018). "First report of carbapenem-resistant Providencia stuartii in Saudi Arabia." New microbes and new infections26: 107-109.
Al-Abdely, H., R. AlHababi, H. M. Dada, H. Roushdy, M. M. Alanazi, A. A. Alessa, N. M. Gad, A. M. Alasmari, E. E. Radwan and H. Al-Dughmani (2021). "Molecular characterization of carbapenem-resistant Enterobacterales in thirteen tertiary care hospitals in Saudi Arabia." Annals of Saudi Medicine41(2): 63-70.
Al-Agamy, M. H., A. Aljallal, H. H. Radwan and A. M. Shibl (2018). "Characterization of carbapenemases, ESBLs, and plasmid-mediated quinolone determinants in carbapenem-insensitive Escherichia coli and Klebsiella pneumoniae in Riyadh hospitals." Journal of infection and public health11(1): 64-68.
Al-Hamad, A., T. Pal, H. Leskafi, H. Abbas, H. Hejles, F. Alsubikhy, D. Darwish, A. Ghazawi and A. Sonnevend (2020). "Molecular characterization of clinical and environmental carbapenem resistant Acinetobacter baumannii isolates in a hospital of the Eastern Region of Saudi Arabia." Journal of infection and public health13(4): 632-636.
Al-Zahrani, Ibrahim, Al-Ahmadi and Bashaer (2021). "Dissemination of VIM-producing Pseudomonas aeruginosa associated with high-risk clone ST654 in a tertiary and quaternary hospital in Makkah, Saudi Arabia." Journal of Chemotherapy33(1): 12-20.
Al-Zahrani, I. A. and B. A. Alasiri (2018). "The emergence of carbapenem-resistant Klebsiella pneumoniae isolates producing OXA-48 and NDM in the Southern (Asir) province, Saudi Arabia." Saudi medical journal39(1): 23.
Al-Zalabani, A., O. A. AlThobyane, A. H. Alshehri, A. O. Alrehaili, M. O. Namankani and O. H. Aljafri (2020). "Prevalence of Klebsiella pneumoniae Antibiotic Resistance in Medina, Saudi Arabia, 2014-2018." Cureus12(8).
Al Bshabshe, A., A. Al-Hakami, B. Alshehri, K. A. Al-Shahrani, A. A. Alshehri, M. B. Al Shahrani, I. Assiry, M. R. Joseph, A. Alkahtani and M. E. Hamid (2020). "Rising Klebsiella pneumoniae infections and its expanding drug resistance in the intensive care unit of a tertiary Healthcare Hospital, Saudi Arabia." Cureus12(8).
Al Hassinah, S., M. Alzayer, L. Okdah, M. Doumith, S. Al Johani, R. Alarfaj, E. Alrashidi, N. Alhuseinan, B. A. Alwan and B. Bakhashween (2020). "Prevalence of Molecular Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa clinical isolates from Saudi Arabia." Journal of Infection and Public Health13(2): 329.
Al Mutair, A., S. Alhumaid, Z. Al Alawi, A. R. Z. Zaidi, A. J. Alzahrani, J. A. Al-Tawfiq, H. Al-Shammari, A. A. Rabaan, O. Khojah and A. Al-Omari (2021). "Five-year resistance trends in pathogens causing healthcare-associated infections at a multi-hospital healthcare system in Saudi Arabia, 2015–2019." Journal of global antimicrobial resistance25: 142-150.
Aleidan, F. A., H. Alkhelaifi, A. Alsenaid, H. Alromaizan, F. Alsalham, A. Almutairi, K. Alsulaiman and A. G. Abdel Gadir (2021). "Incidence and risk factors of carbapenem-resistant Enterobacteriaceae infection in intensive care units: a matched case–control study." Expert Review of Anti-infective Therapy19(3): 393-398.
Alghoribi, M. F., K. Binkhamis, A. A. Alswaji, A. Alhijji, A. Alsharidi, H. H. Balkhy, M. Doumith and A. Somily (2020). "Genomic analysis of the first KPC-producing Klebsiella pneumoniae isolated from a patient in Riyadh: A new public health concern in Saudi Arabia." Journal of infection and public health13(4): 647-650.
Alotaibi, F. (2019). "Carbapenem-resistant Enterobacteriaceae: an update narrative review from Saudi Arabia." Journal of infection and public health12(4): 465-471.
Alotaibi, F. E., E. E. Bukhari, M. M. Al-Mohizea, T. Hafiz, E. B. Essa and Y. I. AlTokhais (2017). "Emergence of carbapenem-resistant Enterobacteriaceae isolated from patients in a university hospital in Saudi Arabia. Epidemiology, clinical profiles and outcomes." Journal of infection and public health10(5): 667-673.
Alqahtani, M., I. Tickler, Z. Al Deesi, W. AlFouzan, A. Al Jabri, R. Al Jindan, S. Al Johani, S. Alkahtani, A. Al Kharusi and E. Mokaddas (2021). "Molecular detection of carbapenem resistance genes in rectal swabs from patients in Gulf Cooperation Council hospitals." Journal of Hospital Infection112: 96-103.
Alzomor, O. A., T. S. Alfawaz, A. Abu-Shaheen, M. A. Alshehri and D. Al Shahrani (2019). "A matched case-control study to assess the carbapenem-resistant Enterobacteriaceae infections among hospitalized children at King Fahad Medical City, Riyadh, Saudi Arabia." Saudi medical journal40(11): 1105.
Aruhomukama, D., C. F. Najjuka, H. Kajumbula, M. Okee, G. Mboowa, I. Sserwadda, R. Mayanja, M. L. Joloba and D. P. Kateete (2019). "Bla VIM-and bla OXA-mediated carbapenem resistance among Acinetobacter baumannii and Pseudomonas aeruginosa isolates from the Mulago hospital intensive care unit in Kampala, Uganda." BMC infectious diseases19(1): 1-8.
Aslam, B., M. Rasool, S. Muzammil, A. B. Siddique, Z. Nawaz, M. Shafique, M. A. Zahoor, R. Binyamin, M. Waseem and M. Khurshid (2020). "Carbapenem resistance: Mechanisms and drivers of global menace." Pathog. Bact.
Bandy, A. and B. Tantry (2021). "ESBL Activity, MDR, and Carbapenem Resistance among Predominant Enterobacterales Isolated in 2019." Antibiotics10(6): 744.
Barber, K. E., J. L. Wagner, R. C. Larry and K. R. Stover (2021). "Frequency of and risk factors for carbapenem-resistant Enterobacteriaceae." Journal of Medical Microbiology70(2).
Codjoe, F. S. and E. S. Donkor (2018). "Carbapenem resistance: a review." Medical Sciences6(1): 1.
De Oliveira, D. M., B. M. Forde, T. J. Kidd, P. N. Harris, M. A. Schembri, S. A. Beatson, D. L. Paterson and M. J. Walker (2020). "Antimicrobial resistance in ESKAPE pathogens." Clinical microbiology reviews33(3): e00181-00119.
Di Domenico, E. G., I. Cavallo, F. Sivori, F. Marchesi, G. Prignano, F. Pimpinelli, I. Sperduti, L. Pelagalli, F. Di Salvo and I. Celesti (2020). "Biofilm Production by Carbapenem-Resistant Klebsiella pneumoniae significantly increases the risk of death in oncological patients." Frontiers in cellular and infection microbiology10.
Di Domenico, E. G., I. Cavallo, F. Sivori, F. Marchesi, G. Prignano, F. Pimpinelli, I. Sperduti, L. Pelagalli, F. Di Salvo and I. Celesti (2021). "Biofilm Production by Carbapenem." Enterobacteriaceae Antimicrobial Agents and Resistance: Relationship with the Therapeutic Approach.
Dortet, L., G. Cuzon, V. Ponties and P. Nordmann (2017). "Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014." Eurosurveillance22(6): 30461.
El-Badawy, M. F., S. F. Abdelwahab, S. A. Alghamdi and M. M. Shohayeb (2019). "Characterization of phenotypic and genotypic traits of carbapenem-resistant Acinetobacter baumannii clinical isolates recovered from a tertiary care hospital in Taif, Saudi Arabia." Infection and drug resistance12: 3113.
Faidah, H. S., A. M. Momenah, H. M. El-Said, A. A. Barhameen, S. S. Ashgar, A. Johargy, A. Elsawy, W. Almalki and S. Al Qurashi (2017). "Trends in the annual incidence of carbapenem resistant among gram negative bacilli in a large teaching hospital in Makah City, Saudi Arabia." Journal of Tuberculosis Research5(04): 229.
Hala, S., C. P. Antony, M. Alshehri, A. O. Althaqafi, A. Alsaedi, A. Mufti, M. Kaaki, B. T. Alhaj-Hussein, H. M. Zowawi and A. Al-Amri (2019). "First report of Klebsiella quasipneumoniae harboring bla KPC-2 in Saudi Arabia." Antimicrobial Resistance & Infection Control8(1): 1-8.
Ibrahim, M. E. (2019). "Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance." Annals of clinical microbiology and antimicrobials18(1): 1-12.
Islam, T. A. B., S. Shamsuzzaman, N. Nehar and J. Fardows (2016). "Prevalence and Antibiogram of Microbial Agents Causing Nosocomial Urinary Tract Infection in Surgical Ward of Dhaka Medical College Hospital." Journal of Enam Medical College6(2): 75-79.
Jawhar, W. N. B., M. M. AlRashed, A. M. Somily and A. M. AlBarrag (2020). "MOLECULAR CHARACTERIZATION OF CARBAPENEM-RESISTANCE GENES AMONG Pseudomonas aeruginosa AND Acinetobacter baumannii CLINICAL ISOLATES IN RIYADH." Pharmacophore11(6).
Julia, L., K. Vilankar, H. Kang, D. E. Brown, A. Mathers and L. E. Barnes (2017). Environmental reservoirs of nosocomial infection: imputation methods for linking clinical and environmental microbiological data to understand infection transmission. AMIA Annual Symposium Proceedings, American Medical Informatics Association.
Khan, M. A., A. M. Mohamed, A. Faiz and J. Ahmad (2019). "Enterobacterial infection in Saudi Arabia: First record of Klebsiella pneumoniae with triple carbapenemase genes resistance." The Journal of Infection in Developing Countries13(04): 334-341.
Khater, E. S., A. A. AlFaki and S. S. Abd Elmoaty (2020). "Carbapenem-Resistant Klebsiella pneumonia Isolated from Patients Admitted in Tertiary Care Hospital in Saudi Arabia." Journal of Advances in Microbiology: 76-85.
Leangapichart, T., P. Gautret, K. Griffiths, K. Belhouchat, Z. Memish, D. Raoult and J.-M. Rolain (2016). "Acquisition of a high diversity of bacteria during the Hajj pilgrimage, including Acinetobacter baumannii with bla OXA-72 and Escherichia coli with bla NDM-5 carbapenemase genes." Antimicrobial agents and chemotherapy60(10): 5942-5948.
Meletis, G. (2016). "Carbapenem resistance: overview of the problem and future perspectives." Therapeutic advances in infectious disease3(1): 15-21.
Mills, J. P., N. J. Talati, K. Alby and J. H. Han (2016). "The epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization and infection among long-term acute care hospital residents." infection control & hospital epidemiology37(1): 55-60.
Morgan, D. J., I. N. Okeke, R. Laxminarayan, E. N. Perencevich and S. Weisenberg (2011). "Non-prescription antimicrobial use worldwide: a systematic review." The Lancet infectious diseases11(9): 692-701.
Mutair, A. A., S. Alhumaid, Z. A. Alawi, A. R. Z. Zaidi, A. J. Alzahrani, J. Al-Tawfiq, H. Al-Shammari, A. Rabaan, O. Khojah and A. Al-Omari (2021). "Five-year resistance trends in pathogens causing healthcare-associated infections at a multi-hospital healthcare system in Saudi Arabia, 2015-2019." Journal of Global Antimicrobial Resistance.
Pittet, D., B. Allegranzi, J. Storr, S. B. Nejad, G. Dziekan, A. Leotsakos and L. Donaldson (2008). "Infection control as a major World Health Organization priority for developing countries." Journal of hospital infection68(4): 285-292.
Pouch, S. M. and M. J. Satlin (2017). "Carbapenem-resistant Enterobacteriaceae in special populations: solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies." Virulence8(4): 391-402.
Shah, M. W., M. Yasir, M. Farman, A. A. Jiman-Fatani, S. B. Almasaudi, M. Alawi, D. El-Hossary and E. I. Azhar (2019). "Antimicrobial susceptibility and molecular characterization of clinical strains of Acinetobacter baumannii in Western Saudi Arabia." Microbial Drug Resistance25(9): 1297-1305.
Sobia, F., S. N. Qurashi and K. Y. Ghailan (2021). "Occurrence of blaCTX-MGp1 and blaCTX-MGp26 in third generation cephalosporin-resistant and carbapenem-resistant bacterial isolates from southwest region of Saudi Arabia-a preliminary study." Saudi Journal of Biological Sciences28(9): 5408-5413.
Ssekatawa, K., D. K. Byarugaba, E. Wampande and F. Ejobi (2018). "A systematic review: the current status of carbapenem resistance in East Africa." BMC research notes11(1): 1-9.
Sundaramoorthy, N. S., S. Thothathri, M. Bhaskaran, A. GaneshPrasad and S. Nagarajan (2021). "Phages from Ganges River curtail in vitro biofilms and planktonic growth of drug resistant Klebsiella pneumoniae in a zebrafish infection model." AMB Express11(1): 1-11.
Talal, L. (2019). "Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae in Bahrain and Saudi Arabia." Journal of Infection and Public Health12(2): 299.
uz Zaman, T., M. Alrodayyan, M. Albladi, M. Aldrees, M. I. Siddique, S. Aljohani and H. H. Balkhy (2018). "Clonal diversity and genetic profiling of antibiotic resistance among multidrug/carbapenem-resistant Klebsiella pneumoniae isolates from a tertiary care hospital in Saudi Arabia." BMC infectious diseases18(1): 1-11.
Weber, D. J., E. E. Sickbert-Bennett, H. Kanamori and W. A. Rutala (2019). "New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility." American journal of infection control47: A29-A38.
Zhu, W., Z. Yuan and H.-y. Zhou (2020). "Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis." Antimicrobial Resistance & Infection Control 9(1): 1-13.
How to Cite
Copyright (c) 2022 Journal of Contemporary Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.